tirzepatide arrived warm Honest TrimRX Review: $279 & Risks Does Tirzepatide Need to Be

GLP-1 medications change the equation at the physiological level

Three dimensional simultaneous brain T 1 , T 2 , and ADC mapping with MR multitasking

Alcoholic hepatitis: from pathogenesis to treatment

From injectables to pills Novo's position as the first company to launch an oral option could help it make up some of the ground it's lost over the past year in the GLP-1 space

"Venglustat represents a potential opportunity for Sanofi Genzyme to expand its core legacy of expertise in lysosomal storage disorders and make an impact on patients living with other rare and challenging diseases," said Sbastien Martel , Global Head of Rare Diseases, Sanofi Genzyme